Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO1 Antikörper (Internal Region)

Verified IDO1 Reaktivität: Human WB, ELISA, IHC Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN185488
  • Target Alle IDO1 Antikörper anzeigen
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Bindungsspezifität
    • 16
    • 10
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 67
    • 31
    • 16
    • 8
    • 1
    • 1
    • 1
    Human
    Wirt
    • 63
    • 11
    • 1
    Ziege
    Klonalität
    • 61
    • 15
    Polyklonal
    Konjugat
    • 47
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IDO1 Antikörper ist unkonjugiert
    Applikation
    • 61
    • 31
    • 21
    • 19
    • 17
    • 15
    • 14
    • 7
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Verwendungszweck
    INDO / IDO
    Sequenz
    CVLANWKKKD PNK
    Kreuzreaktivität
    Hund, Human, Maus, Ratte
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Immunogen
    Peptide with sequence CVLANWKKKDPNK, from the internal region of the protein sequence according to NP_002155.1.
    Isotyp
    IgG
    Top Product
    Discover our top product IDO1 Primärantikörper
  • Applikationshinweise

    Immunohistochemistry: Paraffin embedded Human Placenta. Recommended concentration: 4-6 μg/mL.

    Western Blot: Approx 50 kDa band observed in Human Lymph Node, Spleen and Placenta lysates (calculated MW of 45.3 kDa according to NP_002155.1). Recommended concentration: 0.5-1.5 μg/mL. Primary incubation was 1 hour. Preliminary testing was unsuccessful on

    Peptide ELISA: antibody detection limit dilution 1:128000.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Mohamed, Aboul-Fotouh, Ibrahim, Shehata, Mansour, Yassin, El-Eraky, Abdel-Tawab et al.: "Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-? and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic ..." in: Neuropsychiatric disease and treatment, Vol. 9, pp. 697-708, (2013) (PubMed).

  • Target
    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))
    Andere Bezeichnung
    IDO1 (IDO1 Produkte)
    Synonyme
    INDO antikoerper, ido antikoerper, indo antikoerper, IDO antikoerper, cd107b antikoerper, IDO1 antikoerper, IDO-1 antikoerper, Ido antikoerper, Indo antikoerper, indoleamine 2,3-dioxygenase 1 antikoerper, indoleamine 2,3-dioxygenase 1 L homeolog antikoerper, indoleamine 2,3-dioxygenase 1-like antikoerper, IDO1 antikoerper, ido1.L antikoerper, ido1 antikoerper, Ido1 antikoerper, LOC100050681 antikoerper
    Hintergrund
    IDO1, INDO, indoleamine-pyrrole 2,3 dioxygenase, HGNC:6059, CD107B, IDO, Indoleamine 2,3-dioxygenase, indole 2,3-dioxygenase
    Gen-ID
    3620
    NCBI Accession
    NP_002155
    Pathways
    Activated T Cell Proliferation
Sie sind hier:
Kundenservice